Oral Session 2-11A AML: Clinical Study (1)

[OS2-11A-3] Multicenter feasibility study of clinical sequencing for acute myeloid leukemia

Hisayuki Yokoyama¹, Takahiko Yasuda², Yuichi Ishikawa³, Kensuke Usuki⁴, Shingo Yano⁵, Yoshikazu Ito⁶, Shiro Koh^7,8, Toru Kiguchi⁹, Yasuhiko Miyata¹⁰, Hitoshi Kiyoi³, Itaru Matsumura¹¹, Yasushi Miyazaki¹², Hiroyoshi Hattori², Dai Nishijima², Matsuo Yamamoto², Akiko Saito², Hiroki Kurahashi¹³, Yuichi Shiraishi¹⁴, Satoru Miyano¹⁵, Masashi Sanada², Seishi Ogawa¹⁶, Keizo Horibe^2,17 (1.Department of Hematology, Sendai Medical Center, NHO, Sendai, Japan, 2.Clinical Research Center, Nagoya Medical Center, NHO, Nagoya, Japan, 3.Department of Hematology and Oncology, Nagoya University, Nagoya, Japan, 4.Department of Hematology, NTT Medical Center, Tokyo, Japan, 5.The Jikei University School of Medicine, Tokyo, Japan, 6.Department of Hematology, Tokyo Medical University, Tokyo, Japan, 7.Department of Hematology, Fuchu Hospital, Izumi, Japan, 8.Department of Hematology, Osaka City University, Osaka, Japan, 9.Department of Hematology, Chugoku Central Hospital, Hiroshima, Japan, 10.Department of Hematology, Nagoya Medical Center, NHO, Nagoya, Japan, 11.Department of Hematology, Kindai University Faculty of Medicine, Osaka, Japan, 12.Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan, 13.Division of Molecular Genetics, Fujita Health University, Toyoake, Japan, 14.National Cancer Center, Tokyo, Japan, 15.Human Genome Center, University of Tokyo, Tokyo, Japan, 16.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 17.Department of Pediatrics, Nagoya Medical Center, NHO, Nagoya, Japan)